Iradimed Financial Statements From 2010 to 2026

IRMD Stock  USD 98.09  2.59  2.71%   
Iradimed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Iradimed's valuation are provided below:
Gross Profit
62.1 M
Profit Margin
0.2631
Market Capitalization
1.2 B
Enterprise Value Revenue
14.3874
Revenue
80.5 M
There are over one hundred nineteen available fundamental trends for Iradimed, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Iradimed's regular performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 565.4 M. The current year's Enterprise Value is expected to grow to about 520.3 M

Iradimed Total Revenue

88.44 Million

Check Iradimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Iradimed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 621.7 K, Interest Expense of 702.6 K or Selling General Administrative of 9.9 M, as well as many indicators such as Price To Sales Ratio of 9.68, Dividend Yield of 0.0283 or PTB Ratio of 10.18. Iradimed financial statements analysis is a perfect complement when working with Iradimed Valuation or Volatility modules.
  
Build AI portfolio with Iradimed Stock
Check out the analysis of Iradimed Correlation against competitors.

Iradimed Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets58.6 M113.1 M51.5 M
Slightly volatile
Short and Long Term Debt Total169 K177.9 K1.7 M
Very volatile
Other Current Liabilities2.9 M4.6 M2.5 M
Slightly volatile
Total Current Liabilities6.1 M9.8 M5.5 M
Slightly volatile
Total Stockholder Equity104.8 M99.8 M47.1 M
Slightly volatile
Other Liabilities1.4 M1.6 M1.2 M
Slightly volatile
Property Plant And Equipment Net20.5 M19.5 M5.6 M
Slightly volatile
Current Deferred Revenue1.7 M2.6 M1.5 M
Slightly volatile
Retained Earnings68.6 M65.3 M29 M
Slightly volatile
Accounts Payable1.1 M2.2 MM
Slightly volatile
Cash34.9 M60.1 M30 M
Slightly volatile
Non Current Assets Total27.9 M26.5 M8.2 M
Slightly volatile
Non Currrent Assets Other200 K228.7 K164.6 K
Slightly volatile
Other Assets1.091.15837.6 K
Pretty Stable
Cash And Short Term Investments38.6 M60.1 M32.9 M
Slightly volatile
Net Receivables6.3 M12.1 M5.6 M
Slightly volatile
Common Stock Total Equity1.2 K1.4 K1.1 K
Slightly volatile
Common Stock Shares Outstanding13.1 M14.7 M12 M
Slightly volatile
Liabilities And Stockholders Equity58.6 M113.1 M51.5 M
Slightly volatile
Non Current Liabilities Total2.6 M3.4 M2.2 M
Slightly volatile
Inventory12.6 M12 M5.1 M
Slightly volatile
Other Current Assets1.6 M2.4 M1.3 M
Slightly volatile
Other Stockholder Equity19.6 M34.5 M17.1 M
Slightly volatile
Total Liabilities8.7 M13.2 M7.6 M
Slightly volatile
Property Plant And Equipment Gross26 M24.8 MM
Slightly volatile
Total Current Assets51.5 M86.5 M44.5 M
Slightly volatile
Short Term Debt131 K137.9 K399.7 K
Pretty Stable
Intangible Assets3.7 M3.6 M1.3 M
Slightly volatile
Common Stock1.2 K1.5 K1.1 K
Slightly volatile
Property Plant Equipment1.9 M2.8 M1.7 M
Slightly volatile
Net Tangible Assets50.6 M82.3 M45.5 M
Slightly volatile
Retained Earnings Total Equity30.9 M54.4 M26.7 M
Slightly volatile
Capital Surpluse20.7 M30.4 M19.8 M
Slightly volatile
Deferred Long Term Liabilities1.2 M2.3 M1.3 M
Slightly volatile
Deferred Long Term Asset Charges1.3 M1.3 M711 K
Slightly volatile
Net Invested Capital68.2 M99.8 M52.6 M
Slightly volatile
Net Working Capital61.6 M76.7 M47.3 M
Slightly volatile
Capital Stock1.3 K1.5 K1.2 K
Slightly volatile
Non Current Liabilities Other4.2 M3.8 M2.8 M
Slightly volatile
Capital Lease Obligations132.3 K139.2 K2.3 M
Slightly volatile

Iradimed Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative9.9 M18.3 M8.7 M
Slightly volatile
Selling And Marketing Expenses18.9 M18 M8.3 M
Slightly volatile
Total Revenue88.4 M84.2 M37.9 M
Slightly volatile
Gross Profit68 M64.8 M29.2 M
Slightly volatile
Other Operating Expenses61.9 M59 M28.1 M
Slightly volatile
Research Development1.9 M3.3 M1.7 M
Slightly volatile
EBITDA27.5 M26.2 M10.4 M
Slightly volatile
Cost Of Revenue20.4 M19.4 M8.7 M
Slightly volatile
Total Operating Expenses20.3 M39.5 M18.1 M
Slightly volatile
Net Income Applicable To Common Shares15.5 M14.8 M6.9 M
Slightly volatile
Net Income23.2 M22.1 M8.4 M
Slightly volatile
Net Income From Continuing Ops23.2 M22.1 M8.6 M
Slightly volatile
Interest Income2.6 M2.5 M646.8 K
Slightly volatile
Net Interest Income2.6 M2.5 M683 K
Slightly volatile

Iradimed Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.8 M2.9 M1.6 M
Slightly volatile
Free Cash Flow21.3 M20.3 M7.7 M
Slightly volatile
Begin Period Cash Flow30.5 M57.2 M26.5 M
Slightly volatile
Depreciation805.7 K940.3 K675.3 K
Slightly volatile
Capital Expenditures9.7 M9.2 M2.5 M
Slightly volatile
Total Cash From Operating Activities30.9 M29.5 M10.2 M
Slightly volatile
Net Income23.2 M22.1 M8.4 M
Slightly volatile
End Period Cash Flow34.9 M60.1 M30 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.6810.949.5211
Pretty Stable
Dividend Yield0.02830.02260.0325
Slightly volatile
PTB Ratio10.189.2311.9799
Slightly volatile
Days Sales Outstanding46.7847.3559.1171
Slightly volatile
Book Value Per Share6.486.173.7124
Slightly volatile
Free Cash Flow Yield0.02570.02910.0226
Pretty Stable
Operating Cash Flow Per Share1.911.820.7815
Slightly volatile
Average Payables1.7 M1.6 M966.6 K
Slightly volatile
Stock Based Compensation To Revenue0.04020.0310.0453
Pretty Stable
Capex To Depreciation9.258.813.5839
Slightly volatile
PB Ratio10.189.2311.9799
Slightly volatile
EV To Sales8.8110.128.7981
Slightly volatile
Free Cash Flow Per Share1.311.250.5965
Slightly volatile
ROIC0.190.220.1815
Slightly volatile
Inventory Turnover2.051.871.836
Pretty Stable
Net Income Per Share1.431.370.6496
Slightly volatile
Days Of Inventory On Hand165202207
Pretty Stable
Payables Turnover6.48.027.5799
Slightly volatile
Sales General And Administrative To Revenue0.30.250.2593
Pretty Stable
Average Inventory11 M10.5 MM
Slightly volatile
Research And Ddevelopement To Revenue0.06190.04450.0593
Slightly volatile
Capex To Revenue0.10.09840.0433
Slightly volatile
Cash Per Share2.383.712.6571
Slightly volatile
POCF Ratio46.8231.2745.1794
Slightly volatile
Payout Ratio0.90.820.9369
Slightly volatile
Capex To Operating Cash Flow0.30.280.1802
Slightly volatile
PFCF Ratio59.4345.4856.4905
Pretty Stable
Days Payables Outstanding54.4247.1252.0563
Slightly volatile
Income Quality1.971.531.7618
Very volatile
ROE0.20.250.1997
Slightly volatile
EV To Operating Cash Flow42.7528.9441.8781
Slightly volatile
PE Ratio39.5841.6778.0018
Pretty Stable
Return On Tangible Assets0.170.230.1596
Very volatile
EV To Free Cash Flow54.2742.0852.3016
Slightly volatile
Earnings Yield0.01880.02480.0216
Slightly volatile
Intangibles To Total Assets0.02460.03620.0266
Slightly volatile
Current Ratio6.97.967.726
Slightly volatile
Tangible Book Value Per Share2.995.953.4211
Slightly volatile
Receivables Turnover7.237.986.4854
Slightly volatile
Graham Number14.4613.777.0912
Slightly volatile
Shareholders Equity Per Share6.486.173.7124
Slightly volatile
Debt To Equity0.00190.0020.0557
Slightly volatile
Capex Per Share0.60.570.185
Slightly volatile
Graham Net Net2.293.822.5669
Slightly volatile
Average Receivables3.2 M4.4 M3.7 M
Slightly volatile
Revenue Per Share5.465.22.9973
Slightly volatile
Interest Debt Per Share0.01040.0110.1481
Very volatile
Debt To Assets0.00170.00180.0393
Slightly volatile
Enterprise Value Over EBITDA39.8832.5539.817
Slightly volatile
Short Term Coverage Ratios15815057.8139
Slightly volatile
Price Earnings Ratio39.5841.6778.0018
Pretty Stable
Operating Cycle212250266
Pretty Stable
Price Book Value Ratio10.189.2311.9799
Slightly volatile
Days Of Payables Outstanding54.4247.1252.0563
Slightly volatile
Dividend Payout Ratio0.90.820.9369
Slightly volatile
Price To Operating Cash Flows Ratio46.8231.2745.1794
Slightly volatile
Price To Free Cash Flows Ratio59.4345.4856.4905
Pretty Stable
Ebt Per Ebit0.820.991.0018
Pretty Stable
Company Equity Multiplier1.341.31.2894
Slightly volatile
Long Term Debt To Capitalization0.03330.02540.0336
Slightly volatile
Total Debt To Capitalization0.00190.0020.0506
Slightly volatile
Debt Equity Ratio0.00190.0020.0557
Slightly volatile
Quick Ratio6.236.866.9096
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.291.368.9996
Slightly volatile
Cash Ratio4.385.524.856
Slightly volatile
Cash Conversion Cycle172213216
Very volatile
Operating Cash Flow Sales Ratio0.180.310.2211
Slightly volatile
Days Of Inventory Outstanding165202207
Pretty Stable
Days Of Sales Outstanding46.7847.3559.1171
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.910.790.8363
Slightly volatile
Cash Flow Coverage Ratios15714944.2
Slightly volatile
Price To Book Ratio10.189.2311.9799
Slightly volatile
Fixed Asset Turnover4.724.9617.2
Slightly volatile
Capital Expenditure Coverage Ratio3.53.689.7206
Pretty Stable
Price Cash Flow Ratio46.8231.2745.1794
Slightly volatile
Enterprise Value Multiple39.8832.5539.817
Slightly volatile
Debt Ratio0.00170.00180.0393
Slightly volatile
Cash Flow To Debt Ratio15714944.2
Slightly volatile
Price Sales Ratio9.6810.949.5211
Pretty Stable
Return On Assets0.170.220.155
Very volatile
Asset Turnover0.870.860.869
Slightly volatile
Net Profit Margin0.140.240.1782
Slightly volatile
Gross Profit Margin0.620.690.7499
Slightly volatile
Price Fair Value10.189.2311.9799
Slightly volatile
Return On Equity0.20.250.1997
Slightly volatile

Iradimed Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap565.4 M538.4 M306.8 M
Slightly volatile
Enterprise Value520.3 M495.5 M276.4 M
Slightly volatile

Iradimed Fundamental Market Drivers

Forward Price Earnings45.045
Cash And Short Term Investments52.2 M

Iradimed Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Iradimed Financial Statements

Iradimed stakeholders use historical fundamental indicators, such as Iradimed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Iradimed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Iradimed's assets and liabilities are reflected in the revenues and expenses on Iradimed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Iradimed Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.6 M1.7 M
Total Revenue84.2 M88.4 M
Cost Of Revenue19.4 M20.4 M
Stock Based Compensation To Revenue 0.03  0.04 
Sales General And Administrative To Revenue 0.25  0.30 
Research And Ddevelopement To Revenue 0.04  0.06 
Capex To Revenue 0.10  0.10 
Revenue Per Share 5.20  5.46 
Ebit Per Revenue 0.27  0.18 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Iradimed is a strong investment it is important to analyze Iradimed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iradimed's future performance. For an informed investment choice regarding Iradimed Stock, refer to the following important reports:
Check out the analysis of Iradimed Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.079
Dividend Share
0.68
Earnings Share
1.65
Revenue Per Share
6.335
Quarterly Revenue Growth
0.157
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.